[go: up one dir, main page]

AU3902600A - Compositions and methods for the treatment of immune related diseases - Google Patents

Compositions and methods for the treatment of immune related diseases

Info

Publication number
AU3902600A
AU3902600A AU39026/00A AU3902600A AU3902600A AU 3902600 A AU3902600 A AU 3902600A AU 39026/00 A AU39026/00 A AU 39026/00A AU 3902600 A AU3902600 A AU 3902600A AU 3902600 A AU3902600 A AU 3902600A
Authority
AU
Australia
Prior art keywords
compositions
treatment
methods
related diseases
immune related
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU39026/00A
Inventor
Sherman Fong
Audrey Goddard
Austin L. Gurney
Kenneth J. Hillan
Daniel Tumas
William I. Wood
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Genentech Inc
Original Assignee
Genentech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/US1999/021547 external-priority patent/WO2000015797A2/en
Application filed by Genentech Inc filed Critical Genentech Inc
Publication of AU3902600A publication Critical patent/AU3902600A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4702—Regulators; Modulating activity
    • C07K14/4703—Inhibitors; Suppressors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
AU39026/00A 1999-09-15 2000-03-20 Compositions and methods for the treatment of immune related diseases Abandoned AU3902600A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
PCT/US1999/021547 WO2000015797A2 (en) 1998-09-17 1999-09-15 Compositions and methods for the treatment of immune related diseases
WOUS99/21547 1999-09-15
PCT/US2000/007377 WO2001019991A1 (en) 1999-09-15 2000-03-20 Compositions and methods for the treatment of immune related diseases

Publications (1)

Publication Number Publication Date
AU3902600A true AU3902600A (en) 2001-04-17

Family

ID=22273632

Family Applications (1)

Application Number Title Priority Date Filing Date
AU39026/00A Abandoned AU3902600A (en) 1999-09-15 2000-03-20 Compositions and methods for the treatment of immune related diseases

Country Status (2)

Country Link
AU (1) AU3902600A (en)
WO (1) WO2001019991A1 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1585539A4 (en) * 2002-12-24 2007-01-03 Amgen Inc Wnt-1 inhibitory factor-1 (wif-1) molecules and uses thereof
CN105288019A (en) * 2015-12-03 2016-02-03 济南科纳信息科技有限公司 Traditional Chinese medicine for treating lymphocytic thyroiditis

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000032221A2 (en) * 1998-12-01 2000-06-08 Genentech, Inc. Promotion or inhibition of angiogenesis and cardiovascularization
US6066322A (en) * 1995-03-03 2000-05-23 Millennium Pharmaceuticals, Inc. Methods for the treatment of immune disorders
US5874230A (en) * 1996-07-10 1999-02-23 Tularik, Inc. Assays using TRAF2-associated protein kinase polypeptides
AU4268097A (en) * 1996-09-12 1998-04-02 Human Genome Sciences, Inc. Chemokine alpha-4
AU5383498A (en) * 1996-12-05 1998-06-29 Human Genome Sciences, Inc. Human chemokine beta-13
AU9395998A (en) * 1997-09-17 1999-04-05 Genentech Inc. Compositions and methods for the treatment of immune related diseases
JP2001516580A (en) * 1997-09-17 2001-10-02 ジェネンテック・インコーポレーテッド Secretory and transmembrane polypeptides and nucleic acids encoding them
ES2316175T3 (en) * 1997-11-21 2009-04-01 Genentech, Inc. SPECIFIC ANTIGENS OF PLATQUETS AND THEIR PHARMACOLOGICAL USES.
IL141535A0 (en) * 1998-09-16 2002-03-10 Genentech Inc Secreted and transmembrane polypeptides and nucleic acids encoding the same
IL141551A0 (en) * 1998-09-17 2002-03-10 Genentech Inc Compositions and methods for the treatment of immune related diseases

Also Published As

Publication number Publication date
WO2001019991A1 (en) 2001-03-22

Similar Documents

Publication Publication Date Title
AU7722600A (en) Compositions and methods for the diagnosis and treatment of immune disorders
WO2003072035A8 (en) Compositions and methods for the treatment of immune related diseases
WO2004041170A9 (en) Compositions and methods for the treatment of immune related diseases
IL145470A0 (en) Compositions for the treatment of immune diseases
AU2495200A (en) Compositions and methods for the treatment of tumor
WO2004024097A9 (en) Compositions and methods for the treatment of immune related diseases
AU2003200722A1 (en) Compositions and methods for the treatment of tumor
AU2003200740A1 (en) Compositions and methods for the treatment of tumor
AU2003200731A1 (en) Compositions and methods for the treatment of tumor
AU4205100A (en) Methods and compositions for the treatment of pancreatitis
AU2212299A (en) Compositions and methods for the treatment of tumor
AU2072201A (en) Agents and methods for the treatment of proliferative diseases
AU7748000A (en) Method and composition for the treatment of dermatologic diseases
KR100510795B1 (en) Compositions and Methods for the Treatment of Tumor
AU3632600A (en) Compositions and methods for the treatment of immune related diseases
AUPQ415899A0 (en) Compositions for and methods of treatment of allergic diseases
AU5309600A (en) Compositions and methods for the treatment and diagnosis of immune disorders
AU7743100A (en) Stress protein compositions and methods for prevention and treatment of cancer and infectious disease
HUP0104963A3 (en) Compositions for the treatment of skin diseases
AU9395998A (en) Compositions and methods for the treatment of immune related diseases
AU3840802A (en) Methods and compositions for the treatment of diseases of the eye
AU3434601A (en) Compositions and methods for the treatment of immune related diseases
AU4511201A (en) Compositions and methods for the induction and treatment of retinal detachments
WO2004024076A8 (en) Novel compositions and methods for the treatment of immune related diseases
AU1953701A (en) Methods and compositions for treatment of inflammatory disease

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase